Ductal carcinoma in-situ: An update for clinical practice

Surgical Oncology

Volumn 20, Issue 1, 2011, Pages

  Patani, Neill ^a,b   Khaled, Yazan ^a   Al Reefy, Sara ^a,b   Mokbel, Kefah ^a,b  

^a Princess Grace Hospital   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Ductal carcinoma in situ; Evidence; Local recurrence; Margins; Mastectomy; Radiotherapy; Sentinel lymph node biopsy; Tamoxifen; Wide local excision

Indexed keywords

TAMOXIFEN;

CANCER CLASSIFICATION; CANCER RECURRENCE; CLINICAL PRACTICE; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASTECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; HUMANS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; TAMOXIFEN; TREATMENT OUTCOME;

EID: 78650810251     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2010.08.007     Document Type: Review

References (105)

1. M. Lippman Why study ductal carcinoma in-situ? M.J. Silverstein, A. Recht, M. Lagios, Ductal carcinoma in-situ of the breast 2nd ed. 2002 Lippincott William and Wilkins Philadelphia 12 16
2. E. Netter, P. Troufleau, and J. Stines Ductal carcinoma in-situ of the breast: role of imaging J Radiol 79 1998 651 658
3. W.E. Sumner 3rd, L.G. Koniaris, S.E. Snell, S. Spector, J. Powell, and E. Avisar Results of 23,810 cases of ductal carcinoma-in-situ Ann Surg Oncol 14 5 2007 1638 1643
4. V.L. Ernster, and J. Barclay Increases in ductal carcinoma in-situ (DCIS) of the breast in relation to mammography: a dilemma J Natl Cancer Inst Monogr 22 1997 151 156
5. J.K. Bobo, N.C. Lee, and S.F. Thames Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998 J Natl Cancer Inst 92 2000 971 976
6. E. Pisano, C. Gatsonia, E. Hendrick, M. Yaffe, J. Baum, and S. Acharyya Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group. Diagnostic performance of digital versus film mammography for breast-cancer screening NEJM 353 2005 1773 1783
7. C. Boetes, and J. Veltman Screening women at increased risk with MRI Cancer Imaging 5 Suppl. 2005 23 S10 S15
8. J.H. Menell, E.A. Morris, D.D. Dershaw, A.F. Abramson, E. Brogi, and L. Liberman Determination of the presence and extent of pure ductal carcinoma in-situ by mammography and magnetic resonance imaging Breast J 11 6 2005 382 390
9. C.K. Kuhl, S. Schrading, H.B. Bieling, E. Wardelmann, C.C. Leutner, and R. Koenig MRI for diagnosis of pure ductal carcinoma in-situ: a prospective observational study Lancet 370 9586 2007 485 492
10. A.P. Schouten van der Velden, M.S. Schlooz-Vries, C. Boetes, and T. Wobbes Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review Am J Surg 198 2 2009 262 269
11. K. Mokbel, P.F. Escobar, and T. Matsunaga Mammary ductoscopy: current status and future prospects Eur J Surg Oncol 31 2005 3 8
12. J.J. Going, and D.F. Moffat Escaping from Flatland: clinical and biological aspects of human mammary duct anatomy in three dimensions J Pathol 203 1 2004 538 544
13. L. Zhao, R. Freimanis, S. Bergman, P. Shen, N.D. Perrier, and N. Lesko Biopsy needle technique and the accuracy of diagnosis of atypical ductal hyperplasia for mammographic abnormalities Am Surg 69 2003 757 762
14. A.G. Douglas-Jones, S.K. Gupta, R.L. Attanoos, J.M. Morgan, and R.E. Mansel A critical appraisal of six modern classifications of ductal carcinoma in-situ of the breast (DCIS): correlation with grade of associated invasive carcinoma Histopathology 29 1996 397 409
15. A.G.M. Douglas-Jones, J. Morgan, M.A.C. Appleton, R. Attanoos, A. Caslin, and C. Champ Consistency in the observation of features used to classify duct carcinoma in-situ J Clin Pathol 53 2000 596 602
16. S. Badve, R.P. A'Hern, A.M. Ward, R.R. Millis, S.E. Pinder, and I.O. Ellis Prediction of local recurrence of ductal carcinoma of the breast using five histological classifications. A comparative study with long follow-up Hum Pathol 29 1998 915 923
17. P. Bethwaite, N. Smith, B. Delahunt, and D. Kenwright Reproducibility of new classification schemes for the pathology of ductal carcinoma in-situ of the breast J Clin Pathol 5 1998 450 454
18. W.L. Betsill, P.P. Rosen, P.H. Lieberman, and G.F. Robbins Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone JAMA 239 1978 1863 1867
19. M.E. Sanders, P.A. Schuyler, W.D. Dupont, and D.L. Page The natural history of low-grade ductal carcinoma in-situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up Cancer 103 2005 2481 2484
20. G.D. Leonard, and S.M. Swain Ductal carcinoma in-situ, complexities and challenges J Natl Cancer Inst 96 2004 906 920
21. K. Kerlikowske, A. Molinaro, I. Cha, B.M. Ljung, V.L. Ernster, and K. Stewart Characteristics associated with recurrence among women with ductal carcinoma in-situ treated by lumpectomy J Natl Cancer Inst 95 2003 1692 1702
22. N. Bijker, J.L. Peterse, L. Duchateau, J.P. Julien, I.S. Fentiman, and C. Duval Risk factor for recurrence and metastasis after breast conserving therapy for ductal carcinoma in-situ: analysis of European Organisation for Research and Treatment of Cancer trial 10853 J Clin Oncol 19 2001 2263 227162
23. F. Nakhlis, and M. Morrow Ductal carcinoma in-situ Surg Clin North Am 83 2003 821 839
24. M.A. Ben-David, D.E. Sturtz, K.A. Griffith, K.R. Douglas, J.A. Hayman, and A.S. Lichter Long-term results of conservative surgery and radiotherapy for ductal carcinoma in-situ using lung density correction: the University of Michigan experience Breast J 13 4 2007 392 400
25. S. Di Saverio, F. Catena, D. Santini, L. Ansaloni, T. Fogacci, and S. Mignani 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up Breast Cancer Res Treat 109 3 2008 405 416
26. F.A. Vicini, and A. Recht Age at diagnosis and outcome for women with ductal carcinoma in situ of the breast: a critical review of the literature J Clin Oncol 20 2002 2736 2744
27. B. Fisher, S. Land, E. Mamounas, J. Dignam, E.R. Fisher, and N. Wolmark Prevention of invasive breast cancer in women with ductal carcinoma in-situ: an update of the national surgical adjuvant breast and bowel project experience Semin Oncol 28 2001 400 418 (Pubitemid 32762083)
28. A. Fourquet, B. Zigal-zafrani, and K.B. Clough Breast-conserving surgery plus radiation therapy in ductal carcinoma in-situ: the Institut Curie Experience M.J. Silverstein, A. Recht, M. Lagios, Ductal carcinoma in situ of the breast 2nd ed. 2002 Lippincott William and Wilkins Philadelphia 367 372
29. L.J. Solin, A. Fourquet, F. Vicini, B. Haffty, M. Taylor, and B. McCormick Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation longterm outcome and prognostic significance of patient age and margin status Int J Radiot Oncol Biol Phys 50 2001 991 1102
30. L. Solin, A. Fourquet, F. Vicini, M. Taylor, I.A. Olivotto, and B. Haffty Long-term outcome after breast conservation treatment with radiation for mammographically detected ductal carcinoma in-situ of the breast Cancer 1003 2005 1137 1146 (Pubitemid 40328083)
31. A. Turaka, G.M. Freedman, T. Li, P.R. Anderson, R. Swaby, and N. Nicolaou Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation J Surg Oncol 100 1 2009 25 31
32. G.L. Ottesen, H.P. Graversen, M. Blichert - Toft, I.J. Christensen, and J.A. Andersen Carcinoma in-situ of the female breast. 10-year follow-up results of a prospective nation-wide study Breast Cancer Res Treat 62 2000 197 210
33. B. Cutuli, C. Cohen Solal Le Nir, B. De Lafontan, H. Mignotte, V. Fichet, and R. Fay Breast conserving therapy for ductal carcinoma in-situ of the breast: the French Cancer centers' experience Int J Radiat Oncol Biol Phys 53 2002 868 879
34. G.F. Schwartz, L.J. Solin, I.A. Olivotto, V.L. Ernster, and P.I. Pressman Consensus Conference on the treatment of in situ ductal carcinoma of the breast Cancer 2000 88 April 22-25, 1999 946 954
35. H.R. Mac Donald, M.J. Silverstein, H. Mabry, B. Moorthy, W. Ye, and M.S. Epstein Local control in ductal carcinoma in-situ treated by excision alone: incremental benefit of larger margins Am J Surg 190 2005 521 525
36. A.P. Schouten van der Velden, R. van Vugt, J.A. Van Dijck, J.W. Leer, and T. Wobbes Local recurrences after different treatment strategies for ductal carcinoma in-situ of the breast: a population-based study in the East Netherlands Int J Radiat Oncol Biol Phys 69 3 2007 703 710 (Pubitemid 47418402)
37. M. Morrow, E. Strom, L.W. Basset, D.D. Dershaw, B. Fowble, and A. Giuliano Standard for the management of ductal carcinoma in-situ of the breast Cancer J Clin 52 2002 256 276
38. M.J. Silverstein Margin width as the sole predictor of local recurrence in patients with ductal carcinoma in-situ of the breast M.J. Silverstein, A. Recht, M. Lagios, Ductal carcinoma in-situ of the breast 2nd ed. 2002 Lippincott William and Wilkins Philadelphia 482 493
39. A.C. Neuschatz, T. Di Petrillo, M. Steinhoff, H. Safaii, M. Yunes, and M. Landa The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in-situ of the breast Cancer 94 2002 1917 1924
40. B. Cutuli, A. Fourquet, E. Luporsi, L. Arnold, Y. Caron, and P. De Cremaux Standards, Options et Recommandations Prise en charge des carcinomes canalaires in-situ du sein 2004 www.fnclcc.fr
41. C. Dunne, J.P. Burke, M. Morrow, and M.R. Kell Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ J Clin Oncol 27 10 2009 1615 1620
42. C. Park, J. Schmitt, and A. Recht Joint Center for radiation therapy experience M.J. Silverstein, A. Recht, M. Lagios, Ductal carcinoma in-situ of the breast 2nd ed. 2002 Lippincott William and Wilkins Philadelphia 373 380
43. M.D. Lagios The Lagios experience M.J. Silverstein, A. Recht, M. Lagios, Ductal carcinoma in-situ of the breast 2nd ed. 2002 Lippincott William and Wilkins Philadelphia 303 307
44. M.J. Silverstein, D.N. Poller, J.R. Waisman, W.J. Colburn, A. Barth, and E.D. Gierson Prognostic classification of breast ductal carcinoma in-situ Lancet 345 1995 1154 1157
45. M.D. Lagios, and M.J. Silverstein Ductal carcinoma in-situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomised prospective studies Surg Oncol Clin North Am 6 1997 385 392
46. R. Holland, J.L. Peterse, R.R. Millis, V. Eusebi, D. Faverly, and M.J. van de Vijver Ductal carcinoma in-situ: a proposal for a new classification Semin Diagn Pathol 11 1994 167 180
47. I. Idvall, H. Anderson, A. Ringberg, and M. Ferno Are cellular polarisation and mitotic frequency prognostic factors for local recurrence in patients with ductal carcinoma in-situ of the breast? Eur J Cancer 39 2003 1704 1710
48. L.S. Phillips, R.C. Millikan, J.C. Schroeder, J.S. Barnholtz-Sloan, and B.J. Levine Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast Cancer Epidemiol Biomarkers Prev 18 5 2009 May 1507 1514
49. M.J. Silverstein The University of Southern California/Van Nuys prognostic index for ductal carcinoma in-situ of the breast Am J Surg 186 2003 337 343
50. M.J. Silverstein, D.N. Poller, P. Craig, J.R. Waisman, B.S. Lewinsky, and W.J. Colburn A prognostic index for ductal carcinoma in-situ of the breast classification Cancer 77 1996 2267 2274 (Pubitemid 26162419)
51. M.J. Silverstein, and C. Buchanan Ductal carcinoma in-situ: USC/VAN NUYS prognostic index and the impact of margin status Breast 12 2003 457 471
52. B. Cutuli, C. Lemanski, C. Cohen-Solal, B. De Lafontan, H. Mignotte, and V. Servent Ductal carcinoma in-situ (DCIS) of the breast: what is the safest treatment? Int J Rad Oncol Biol Phys 57 Suppl. 2 2003 S361
53. T. Baqai, and S. Shousha Oestrogen receptor negativity as a marker for high grade ductal carcinoma in-situ of the breast Histopathology 42 2003 440 447
54. E. Provenzano, J.L. Hopper, G.G. Giles, G. Marr, D.J. Venter, and J.E. Armes Biological markers that predict recurrence in ductal carcinoma in-situ of the breast Eur J Cancer 39 5 2003 622 630
55. R.E. Roses, E.C. Paulson, A. Sharma, J.E. Schueller, H. Nisenbaum, and S. Weinstein HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer Cancer 39 2003 622 630
56. H. Buerger, F. Otterbach, R. Simon, C. Poremba, R. Diallo, and T. Decker Comparative genomic hybridization of ductal carcinoma in-situ of the breast - evidence of multiple genetic pathways J Pathol 187 1999 396 402
57. M. Aubele, A. Mattis, H. Zitzelsberger, A. Walch, M. Kremer, and G. Welzl Extensive ductal carcinoma in-situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH Int J Cancer 85 2000 82 86
58. J. Hannemann, A. Velds, J.B. Halfwerk, B. Kreike, J.L. Peterse, and M.J. van de Vijver Classification of ductal carcinoma in-situ by gene expression profiling Breast Cancer Res 8 5 2006 R61
59. R.L. Balleine, L.R. Webster, S. Davis, E.L. Salisbury, J.P. Palazzo, and G.F. Schwartz Molecular grading of ductal carcinoma in situ of the breast Clin Cancer Res 14 24 2008 Dec 15 8244 8252
60. J.D. Wulfkuhle, D.C. Sgroi, H. Krutzsch, K. McLean, K. McGarvey, and M. Knowlton Proteomics of human breast ductal carcinoma in-situ Cancer Res 62 2002 6740 6749
61. M. Gotte, C. Kersting, I. Radke, L. Kiesel, and P. Wulfing An expression signature of syndecan- 1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in-situ Breast Cancer Res 9 1 2007 R8
62. P. Van der Groep, P.J. van Diest, F.H. Menko, J. Bart, E.G. de Vries, and E. van der Wall Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers J Clin Pathol 62 10 2009 Oct 926 930 [Epub 2009 Jun 18]
63. J. Boyages, G. Delaney, and R. Taylor Predictors of local recurrence after treatment of ductal carcinoma in-situ. A meta-analysis Cancer 85 1999 616 628
64. M. Douek, and M. Baum Mass breast screening: is there a hidden cost? Br J Surg 90 Suppl. 1 2003, June: (Abstract Breast 14)
65. N. Baxter, B.A. Virnig, J.B. Durham, and T.M. Tuttle Trend in treatment of ductal carcinoma in situ of the breast Natl Cancer Inst 96 2004 443 448 (Pubitemid 38443647)
66. A. Kricker, and B. Amstrong Surgery and outcome of ductal carcinoma in-situ of the breast: a population-based study in Australia Eur J Cancer 40 2004 2396 2402
67. V.L. Ernster, J. Barclay, K. Kerlikowske, H. Wilkie, and R. Ballard-Barbash Mortality among women with ductal carcinoma in-situ of the breast in the population-based surveillance, epidemiology and end results program Arch Intern Med 160 2000 953 958
68. B. Cutuli, C. Lemanski, A. Fourquet, B. de Lafontan, S. Giard, and A. Meunier French National Survey on DCIS: analysis of clinico-pathological features and treatments in 1289 patients Eur J Cancer 3 Suppl. 2 2005 77 Abs 274
69. B. Cutuli, C. Lemanski, A. Fourquet, B. de Lafontan, S. Giard, and A. Meunier Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience Br J Cancer 100 7 2009 Apr 7 1048 1054 Epub 2009 Mar 10
70. G.H. Cunnick, and K. Mokbel Skin-sparing mastectomy Am J Surg 188 2004 78 84
71. A. Ringberg, I. Idvall, M. Ferno, H. Anderson, L. Anagnostaki, and P. Boiesen Ipslitateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in-situ of the breast Eur J Surg Oncol 26 2000 444 451
72. L. Cataliotti, V. Distante, L. Orzalesi, S. Bianchi, S. Ciatto, and R. Simoncini The Florence experience M.J. Silverstein, A. Recht, M. Lagios, Ductal Carcinoma in-situ of the breast 2nd ed. 2002 Lippincott William and Wilkins Philadelphia 348 353
73. C. Tunon de Lara, I. De Mascarel, G. Mac Grogan, E. Stöckle, O. Jourdain, and V. Acharian Analysis of 676 ductal carcinoma in-situ (DCIS) of the breast from 1971 to 1995: diagnosis and treatment; the experience of one institute Am J Clin Oncol 24 2001 531 536
74. B. Cutuli, C. Lemanski, and M. Le Blanc Local recurrences after DCIS therapy: diagnosis, treatment and outcome Breast Cancer Res Treat 76 Suppl. 1 2002 S36 Abs 31
75. G.F. Schwartz Treatment of subclinical ductal carcinoma in-situ of the breast by local excision and surveillance: an update personal experience M.J. Silverstein, A. Recht, M. Lagios, Ductal carcinoma in-situ of the breast 2nd ed. 2002 Lippincott William and Wilkins Philadelphia 308 321
76. L.G. Arnesson, and K. Olsen Linköping experience M.J. Silverstein, Ductal carcinoma in-situ of the breast 1997 Williams and Wilkins Baltimore 373 377
77. J.S. Wong, M.A. Gado, C. Gelman, C.M. Kaelin, S.L. Troyan, and S.C. Lester Wide excision alone for ductal carcinoma in-situ (DCIS) of the breast Proc Am Soc Clin Oncol 22 2003 12 (Abs 44)
78. M.J. Silverstein An argument against routine use of radiotherapy for ductal carcinoma in situ Oncology 17 2003 1 23
79. N. Bijker, P.H. Meijnen, J. Bogaerts, and J.L. Peterse Radiotherapy in breast conserving treatment for ductal carcinoma in-situ (DCIS): ten year results of European Organization for research and Treatment of Cancer (EORTC) randomized trial 10853 Breast Cancer Res Treat 94 Suppl. 1 2005 s57
80. UK Coordinating committee on Cancer Research (UKCCCR) Ductal Carcinoma in-situ Working Party Radiotherapy and Tamoxifen in women with completely excised ductal carcinoma in-situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial Lancet 362 2003 95 102
81. S.O. Emdin, B. Granstrand, A. Ringberg, K. Sandelin, L.G. Arnesson, and H. Nordgren Swedish Breast Cancer Group. SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening Acta Oncol 45 5 2006 536 543
82. A. Goodwin, S. Parker, D. Ghersi, and N. Wilcken Post-operative radiotherapy for ductal carcinoma in situ of the breast Cochrane Database Syst Rev 4 2009 Oct 7 CD000563
83. G.A. Viani, E.J. Stefano, S.L. Afonso, L.I. De Fendi, F.V. Soares, and P.G. Leon Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in-situ: a meta-analysis of randomized trials Radiat Oncol 2 1 2007 28
84. B. Fowble Overview of conservative surgery and radiation therapy: ductal carcinoma in-situ M.J. Silverstein, A. Recht, M. Lagios, Ductal carcinoma in-situ of the breast 2nd ed. 2002 Lippincott William and Wilkins Philadelphia 287 302
85. J.L. Warren, D.L. Weaver, T. Bocklage, C.R. Key, C.E. Platz, and K.A. Cronin The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS. A population-based analysis Cancer 104 2005 1840 1848
86. R. Yerushalmi, A. Sulkes, M. Mishaeli, A. Neumann, M. Dinerman, and J. Sulkes Radiation treatment for ductal carcinoma in-situ (DCIS): is a boost to the tumor bed necessary? Neoplasma 53 6 2006 507 510
87. J.S. Vaidya Partial breast irradiation using targeted intraoperative radiotherapy (Targit) Nat Clin Pract Oncol 4 7 2007 Jul 384 385
88. F. Vicini, P.D. Beitsch, C.A. Quiet, A.J. Keleher, D. Garcia, and H.C. Snider Jr. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI) Cancer 112 4 2008 Feb 15 758 766
89. P.Z. Israel, F. Vicini, A.B. Robbins, P. Shroff, M. McLaughlin, and K. Grier Ductal carcinoma in situ of the breast treated with accelerated partial breast irradiation using balloon-based brachytherapy Ann Surg Oncol 2010 May 5 [Epub ahead of print]
90. B. Fisher, J. Dignam, N. Wolmark, D.L. Wickerham, E.R. Fisher, and E. Mamounas Tamoxifen in treatment of intraductal breast cancer: national Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial Lancet 353 1999 1993 2000 (Pubitemid 29271743)
91. B. Fisher, S. Land, E. Mamounas, J. Dignam, E.R. Fisher, and N. Wolmark Prevention of invasive breast cancer in women with ductal carcinoma in-situ: an update of the National Surgical Adjuvant Breast and Bowel Project Experience M.J. Silverstein, A. Recht, M. Lagios, Ductal carcinoma in-situ of the breast 2nd ed. 2002 Lippincott William and Wilkins Philadelphia 432 446
92. D.C. Allred, J. Bryant, S. Lano, S. Paik, E. Fisher, and T. Julian Estrogen receptor expression as a predictive marker of the effectiveness of tamoxifen in the treatment of DCIS: findings from NSABP protocol B-24 Breast Cancer Res Treat 76 Suppl. 1 2002 536 Abs 30
93. S.J. Schnitt The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin Breast Cancer Res 11 1 2009 101 Epub 2009 Feb 27
94. M. Hu, G. Peluffo, H. Chen, R. Gelman, S. Schnitt, and K. Polyak Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast Proc Natl Acad Sci U S A 106 9 2009 Mar 3 3372 3377 Epub 2009 Feb 13
95. N.J. Bundred, A. Cramer, J. Morris, L. Renshaw, K.L. Cheung, and P. Flint Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial Clin Cancer Res 16 5 2010 Mar 1 1605 1612 Epub 2010 Feb 23
96. K. Mokbel, and B. Cutuli Heterogeneity of ductal carcinoma in-situ and its effects on management Lancet Oncol 7 2006 756 765
97. P. Veronesi, M. Intra, A.R. Vento, P. Naninato, P. Caldarella, and G. Paganelli Sentinel node biopsy for localised ductal carcinoma in-situ? Breast 14 2005 520 522
98. T.B. Julian, S.R. Land, V. Fourchotte, S.R. Haile, E.R. Fisher, and E.P. Mamounas Is sentinel node biopsy necessary in conservatively treated DCIS? Ann Surg Oncol 8 2007 2202 2208
99. M.J. Silverstein, M.D. Lagios, S. Martino, B.S. Lewinsky, P.H. Craig, and P.J. Beron Outcome after invasive local recurrence inpatients with ductal carcinoma in-situ of the breast J Clin Oncol 16 1998 1367 1373
100. Cutuli B, Lemanski C, Le Blanc-Onfroy M et al. DCIS local recurrence: diagnosis, treatment modalities and long-term outcome. Anal 195 Cases. Unpublished - Personal Communication.
101. L. Solin, A. Fourquet, F. Vicini, B. Haffty, M. Taylor, and B. McCormick Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in-situ Eur J Cancer 41 2005 1715 1723
102. B. Cutuli, C. Borel, F. Dhermain, S.M. Magrini, T.H. Wasserman, and J.A. Bogart Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases Radioth Oncol 59 2001 247 255
103. B. Cutuli, J.M. Dilhuydy, B. De Lafontan, J. Berlie, M. Lacroze, and F. Lesaunier Ductal carcinoma in-situ of the male breast: analysis of 31 cases Eur J Cancer 33 1997 35 38
104. A.P. Hittmair, R.A. Lininger, and F.A. Tavassoli Ductal carcinoma in-situ (DCIS) in the male breast. A morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma: a preliminary report Cancer 83 1998 2139 2149
105. J.F. Head, and R.L. Elliott Stereotactic radiofrequency ablation: a minimally invasive technique for nonpalpable breast cancer in postmenopausal patients Cancer Epidemiol 33 3-4 2009 300 305